Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

17.00
+0.10070.60%
Volume:521.20K
Turnover:8.84M
Market Cap:1.52B
PE:-6.77
High:17.42
Open:16.91
Low:16.78
Close:16.90
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:0.66
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:100.54
PE(LYR):-5.16

Loading ...

Syndax CEO Michael Metzger Disposes of Common Shares Worth $784,274.98

Reuters
·
Jul 10

Why Syndax Pharmaceuticals (SNDX) Is Up 6.3% After Broad Russell Value Index Removal And What's Next

Simply Wall St.
·
Jul 08

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Jul 07

Etoro Data Show Retail Investors Pile into Memory Stocks as AI Data Center Demand Strains Supply

Reuters
·
Jul 06

Pre-Market Surge for U.S. Memory Chip Stocks as Semiconductor Sector Receives Major Update

Deep News
·
Jul 06

Syndax Pharmaceuticals (SNDX) Reports Strong Revuforj Data, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 05

Top 20 US Stocks by Trading Volume on July 3: Tesla Caps Employee AI Spending at $200 Weekly

Deep News
·
Jul 03

Syndax Grants Stock Option Inducement Awards for 250,700 Shares to Eight New Employees

Reuters
·
Jul 02

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 02

These were the Best and Worst S&P 500 Stocks for the Second Quarter

Dow Jones
·
Jul 01

Does Syndax Pharmaceuticals’ (SNDX) Russell Value Index Exit Quietly Recast Its Liquidity And Risk Narrative?

Simply Wall St.
·
Jun 29

Pre-Market: Tech and Chip Stocks Under Renewed Selling Pressure, Nasdaq Futures Slide

Deep News
·
Jun 26

AI stock slump raises the question if investors are just taking profits or getting very nervous

Bloomberg
·
Jun 24

Is Strong SAVE Trial Data Altering The Investment Case For Syndax Pharmaceuticals (SNDX)?

Simply Wall St.
·
Jun 21

Semiconductor Stocks Lead Market Surge, US Equity Funds See Record Inflows, Nikkei Hits 70,000

Deep News
·
Jun 20

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 15

Syndax Pharmaceuticals (SNDX) Stock Valuation After Positive SAVE Trial Data In High-Risk Leukemia

Simply Wall St.
·
Jun 15

Syndax Head of R&D, CMO Nicholas A.J. Botwood disposes of USD 1,183,151 in common shares

Reuters
·
Jun 13

Syndax Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 12

Syndax price target lowered to $31 from $34 at Guggenheim

TIPRANKS
·
Jun 12